|
GB796524A
(en)
|
1956-03-21 |
1958-06-11 |
Hickson & Welch Ltd |
Improvements in or relating to optical whitening agents
|
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
HU204253B
(en)
|
1982-11-22 |
1991-12-30 |
Sandoz Ag |
Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
|
|
US4828991A
(en)
|
1984-01-31 |
1989-05-09 |
Akzo N.V. |
Tumor specific monoclonal antibodies
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
CA1283827C
(en)
|
1986-12-18 |
1991-05-07 |
Giorgio Cirelli |
Appliance for injection of liquid formulations
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4885314A
(en)
|
1987-06-29 |
1989-12-05 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
|
US4782084A
(en)
|
1987-06-29 |
1988-11-01 |
Merck & Co., Inc. |
HMG-COA reductase inhibitors
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5420245A
(en)
|
1990-04-18 |
1995-05-30 |
Board Of Regents, The University Of Texas |
Tetrapeptide-based inhibitors of farnesyl transferase
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
EP0604181A1
(en)
|
1992-12-21 |
1994-06-29 |
Eli Lilly And Company |
Antitumor compositions and method of treatment
|
|
WO1994019357A1
(en)
|
1993-02-23 |
1994-09-01 |
Merrell Dow Pharmaceuticals Inc. |
Farnesyl:protein transferase inhibitors as anticancer agents
|
|
CA2118985A1
(en)
|
1993-04-02 |
1994-10-03 |
Dinesh V. Patel |
Heterocyclic inhibitors of farnesyl protein transferase
|
|
US5843941A
(en)
|
1993-05-14 |
1998-12-01 |
Genentech, Inc. |
Ras farnesyl transferase inhibitors
|
|
US5602098A
(en)
|
1993-05-18 |
1997-02-11 |
University Of Pittsburgh |
Inhibition of farnesyltransferase
|
|
EP0670314A4
(en)
|
1993-09-22 |
1996-04-10 |
Kyowa Hakko Kogyo Kk |
FARNESYL TRANSFERASE INHIBITORS.
|
|
JP2875393B2
(ja)
|
1993-10-15 |
1999-03-31 |
シェーリング コーポレイション |
Ｇ−タンパク質機能の阻害および増殖性疾患の治療に有用な三環式カルバメート化合物
|
|
MY134819A
(en)
|
1993-10-15 |
2007-12-31 |
Schering Corp |
Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US5719148A
(en)
|
1993-10-15 |
1998-02-17 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US5721236A
(en)
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
US5661152A
(en)
|
1993-10-15 |
1997-08-26 |
Schering Corporation |
Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
IL111235A
(en)
|
1993-10-15 |
2001-03-19 |
Schering Plough Corp |
Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
|
|
JPH09504295A
(ja)
|
1993-10-25 |
1997-04-28 |
パーク・デイビス・アンド・カンパニー |
タンパク質：ファルネシルトランスフェラーゼの置換されたテトラ‐およびペンタペプチド阻害剤
|
|
US5783593A
(en)
|
1993-11-04 |
1998-07-21 |
Abbott Laboratories |
Inhibitors of squalene synthetase and protein farnesyltransferase
|
|
CA2152822A1
(en)
|
1993-11-04 |
1995-05-11 |
William R. Baker |
Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
|
|
KR100362338B1
(ko)
|
1993-11-05 |
2003-04-08 |
워너-램버트 캄파니 |
단백질:파르네실트랜스퍼라아제의치환디-및트리펩티드억제제
|
|
US5484799A
(en)
|
1993-12-09 |
1996-01-16 |
Abbott Laboratories |
Antifungal dorrigocin derivatives
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
CA2185441A1
(en)
|
1994-03-15 |
1995-09-21 |
Michael D. Lewis |
Isoprenyl transferase inhibitors
|
|
US6312699B1
(en)
|
1994-03-28 |
2001-11-06 |
Uab Research Foundation |
Ligands added to adenovirus fiber
|
|
HUT72440A
(en)
|
1994-03-31 |
1996-04-29 |
Bristol Myers Squibb Co |
Imidazole-containing inhibitors of farnesyl protein transferase and pharmaceutical compositions containing them
|
|
US5523430A
(en)
|
1994-04-14 |
1996-06-04 |
Bristol-Myers Squibb Company |
Protein farnesyl transferase inhibitors
|
|
US5510510A
(en)
|
1994-05-10 |
1996-04-23 |
Bristol-Meyers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US5563255A
(en)
|
1994-05-31 |
1996-10-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
|
EP0764149B1
(fr)
|
1994-06-10 |
1999-01-20 |
Aventis Pharma S.A. |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5571792A
(en)
|
1994-06-30 |
1996-11-05 |
Warner-Lambert Company |
Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
|
|
CA2155448A1
(en)
|
1994-08-11 |
1996-02-12 |
Katerina Leftheris |
Inhibitors of farnesyl protein transferase
|
|
DE69514367T2
(de)
|
1994-08-11 |
2000-07-27 |
Banyu Pharmaceutical Co., Ltd. |
Substituierte amidderivate
|
|
EP0805154A1
(en)
|
1994-08-12 |
1997-11-05 |
Banyu Pharmaceutical Co., Ltd. |
N,n-disubstituted amic acid derivative
|
|
JPH10510261A
(ja)
|
1994-12-09 |
1998-10-06 |
ワーナー−ランバート・カンパニー |
タンパク質：ファルネシルトランスフェラーゼの置換テトラーおよびペンタペプチド阻害剤
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
WO1996021456A1
(en)
|
1995-01-12 |
1996-07-18 |
University Of Pittsburgh |
Inhibitors of prenyl transferases
|
|
FR2729390A1
(fr)
|
1995-01-18 |
1996-07-19 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2730492B1
(fr)
|
1995-02-09 |
1997-03-14 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2730491B1
(fr)
|
1995-02-09 |
1997-03-14 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5700806A
(en)
|
1995-03-24 |
1997-12-23 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
US5684013A
(en)
|
1995-03-24 |
1997-11-04 |
Schering Corporation |
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
|
US5712280A
(en)
|
1995-04-07 |
1998-01-27 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
IL117798A
(en)
|
1995-04-07 |
2001-11-25 |
Schering Plough Corp |
Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
|
|
EP0820452B1
(en)
|
1995-04-07 |
2003-06-04 |
Schering Corporation |
Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
|
|
US5891872A
(en)
|
1995-04-07 |
1999-04-06 |
Schering Corporation |
Tricyclic compounds
|
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
|
IL118101A0
(en)
|
1995-05-03 |
1996-09-12 |
Abbott Lab |
Inhibitors of farnesyltransferase
|
|
WO1997000252A1
(en)
|
1995-06-16 |
1997-01-03 |
Warner-Lambert Company |
Tricyclic inhibitors of protein farnesyltransferase
|
|
FR2736641B1
(fr)
|
1995-07-10 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2736638B1
(fr)
|
1995-07-12 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
CH690163A5
(fr)
|
1995-07-28 |
2000-05-31 |
Symphar Sa |
Dérivés gem-diphosphonates substitués utiles en tant qu'agents anti-cancers.
|
|
CN1066147C
(zh)
|
1995-11-01 |
2001-05-23 |
诺瓦提斯公司 |
嘌呤衍生物及其制备方法
|
|
ATE236632T1
(de)
|
1995-11-06 |
2003-04-15 |
Univ Pittsburgh |
Inhibitoren der protein-isoprenyl-transferase
|
|
CA2238081A1
(en)
|
1995-11-22 |
1997-05-29 |
S. Jane Desolms |
Inhibitors of farnesyl-protein transferase
|
|
DE69635966T2
(de)
|
1995-12-08 |
2006-11-30 |
Janssen Pharmaceutica N.V. |
(Imidazol-5-yl)Methyl-2-Chinolinonderivate als Farnesyl Protein transferase Inhibitoren
|
|
SK86198A3
(en)
|
1995-12-22 |
1999-02-11 |
Schering Corp |
Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
AU1529997A
(en)
|
1996-01-16 |
1997-08-11 |
Warner-Lambert Company |
Substituted histidine inhibitors of protein farnesyltransferase
|
|
US6673927B2
(en)
|
1996-02-16 |
2004-01-06 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Farnesyl transferase inhibitors
|
|
EP0944388A4
(en)
|
1996-04-03 |
2001-08-16 |
Merck & Co Inc |
INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
|
|
WO1997044350A1
(en)
|
1996-05-22 |
1997-11-27 |
Warner-Lambert Company |
Inhibitors of protein farnesyl transferase
|
|
CA2260216A1
(en)
|
1996-07-15 |
1998-01-22 |
Bristol-Myers Squibb Company |
Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
|
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
|
AU6013998A
(en)
|
1996-12-30 |
1998-07-31 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
CA2276150A1
(en)
|
1996-12-30 |
1998-07-09 |
Steven D. Young |
Inhibitors of farnesyl-protein transferase
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6262096B1
(en)
|
1997-11-12 |
2001-07-17 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
|
US6040321A
(en)
|
1997-11-12 |
2000-03-21 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
|
US6214852B1
(en)
|
1998-10-21 |
2001-04-10 |
Bristol-Myers Squibb Company |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
|
JP2002536968A
(ja)
|
1999-01-29 |
2002-11-05 |
イムクローン システムズ インコーポレイティド |
Ｋｄｒに特異的な抗体およびその使用
|
|
GB9903762D0
(en)
|
1999-02-18 |
1999-04-14 |
Novartis Ag |
Organic compounds
|
|
GB9904387D0
(en)
|
1999-02-25 |
1999-04-21 |
Pharmacia & Upjohn Spa |
Antitumour synergistic composition
|
|
EP1187633A4
(en)
|
1999-04-08 |
2005-05-11 |
Arch Dev Corp |
USE OF ANTI-VEGF ANTIBODIES TO ENHANCE RADIATION IN ANTICANCER THERAPY
|
|
US6329380B1
(en)
|
1999-06-30 |
2001-12-11 |
Merck & Co., Inc. |
SRC kinase inhibitor compounds
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
MXPA02002559A
(es)
|
1999-09-10 |
2002-07-30 |
Merck & Co Inc |
Inhibidores de tirosina cinasa.
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
KR20020088406A
(ko)
|
1999-09-17 |
2002-11-27 |
애보트 게엠베하 운트 콤파니 카게 |
치료제로서의 피라졸로피리미딘
|
|
MY125768A
(en)
|
1999-12-15 |
2006-08-30 |
Bristol Myers Squibb Co |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
|
TWI284639B
(en)
|
2000-01-24 |
2007-08-01 |
Shionogi & Co |
A compound having thrombopoietin receptor agonistic effect
|
|
CA2416527C
(en)
|
2000-08-10 |
2009-12-22 |
Pharmacia Italia S.P.A. |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
EP1377579B1
(en)
|
2000-10-31 |
2009-03-25 |
Aventis Pharmaceuticals Inc. |
Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
|
|
US7429599B2
(en)
|
2000-12-06 |
2008-09-30 |
Signal Pharmaceuticals, Llc |
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
|
|
BR0116493A
(pt)
|
2000-12-21 |
2003-09-30 |
Vertex Pharma |
Compostos de pirazol úteis como inibidores de proteìna cinase
|
|
ES2257461T3
(es)
|
2000-12-21 |
2006-08-01 |
Bristol-Myers Squibb Company |
Inhibidores de tiazolilo de tirosina quinasas de la familia tec.
|
|
FR2818642B1
(fr)
|
2000-12-26 |
2005-07-15 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
|
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
|
MXPA03008888A
(es)
|
2001-03-29 |
2005-03-07 |
Vertex Pharma |
Inhibidores de n-terminal c-jun cinasas (jnk) y otras proteinas cinasas.
|
|
AU2002247847A1
(en)
|
2001-04-09 |
2002-10-21 |
Lorantis Limited |
Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
|
|
US6881737B2
(en)
|
2001-04-11 |
2005-04-19 |
Amgen Inc. |
Substituted triazinyl acrylamide derivatives and methods of use
|
|
JP2002338537A
(ja)
|
2001-05-16 |
2002-11-27 |
Mitsubishi Pharma Corp |
アミド化合物およびその医薬用途
|
|
FR2825278A1
(fr)
|
2001-05-30 |
2002-12-06 |
Sod Conseils Rech Applic |
Produit comprenant du mikanolide, du dihydromikanolide ou un analogue de ceux-ci en association avec un autre agent anti-cancereux pour une utilisation therapeutique dans le traitement du cancer
|
|
WO2002096905A1
(en)
|
2001-06-01 |
2002-12-05 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinases
|
|
CA2450769A1
(en)
|
2001-06-15 |
2002-12-27 |
Vertex Pharmaceuticals Incorporated |
5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
|
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
WO2003026665A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
|
|
AU2002353186A1
(en)
|
2001-12-19 |
2003-06-30 |
Smithkline Beecham P.L.C. |
(1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
|
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
WO2003095448A1
(en)
|
2002-05-06 |
2003-11-20 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
|
WO2003097610A1
(en)
|
2002-05-17 |
2003-11-27 |
Pharmacia Italia S.P.A. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
WO2004000214A2
(en)
|
2002-06-19 |
2003-12-31 |
Bristol-Myers Squibb Company |
Use of compounds having an amine nucleus in manufacture of a medicament useful for treating factor viia-associated conditions
|
|
TW200401638A
(en)
|
2002-06-20 |
2004-02-01 |
Bristol Myers Squibb Co |
Heterocyclic inhibitors of kinases
|
|
US7361665B2
(en)
|
2002-07-09 |
2008-04-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
|
|
TWI329112B
(en)
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
|
JP4881558B2
(ja)
|
2002-09-04 |
2012-02-22 |
シェーリング コーポレイション |
サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン
|
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
DE60313872T2
(de)
|
2002-09-04 |
2008-01-17 |
Schering Corp. |
Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
|
|
CN100376580C
(zh)
|
2002-09-04 |
2008-03-26 |
先灵公司 |
作为细胞周期蛋白依赖性激酶抑制剂的吡唑并嘧啶
|
|
US7205308B2
(en)
|
2002-09-04 |
2007-04-17 |
Schering Corporation |
Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US20050250837A1
(en)
|
2002-10-18 |
2005-11-10 |
D Mello Santosh R |
Use of C-Raf inhibitors for the treatment of neurodegenerative diseases
|
|
ES2273047T3
(es)
|
2002-10-28 |
2007-05-01 |
Bayer Healthcare Ag |
Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa.
|
|
UA81790C2
(uk)
*
|
2002-12-19 |
2008-02-11 |
Фармация Италия С.П.А. |
Заміщені піролопіразольні похідні як інгібітори кінази
|
|
FR2850022B1
(fr)
|
2003-01-22 |
2006-09-08 |
Centre Nat Rech Scient |
Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications
|
|
EP1594854B1
(en)
|
2003-02-06 |
2010-09-01 |
Bristol-Myers Squibb Company |
Thiazolyl-based compounds useful as kinase inhibitors
|
|
JP2006518368A
(ja)
|
2003-02-21 |
2006-08-10 |
ファイザー・インク |
プロテインキナーゼ阻害剤としてのｎ−ヘテロシクリル置換アミノチアゾール誘導体
|
|
GB0304665D0
(en)
|
2003-02-28 |
2003-04-02 |
Teijin Ltd |
Compounds
|
|
JP4564485B2
(ja)
|
2003-02-28 |
2010-10-20 |
帝人ファーマ株式会社 |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
GB0305142D0
(en)
|
2003-03-06 |
2003-04-09 |
Eisai London Res Lab Ltd |
Synthesis
|
|
GB0305559D0
(en)
|
2003-03-11 |
2003-04-16 |
Teijin Ltd |
Compounds
|
|
ATE396731T1
(de)
|
2003-03-25 |
2008-06-15 |
Vertex Pharma |
Thiazole zur verwendung als inhibitoren von protein-kinasen
|
|
WO2004087707A1
(en)
|
2003-03-31 |
2004-10-14 |
Vernalis (Cambridge) Limited |
Pyrazolopyrimidine compounds and their use in medicine
|
|
WO2004100868A2
(en)
|
2003-04-23 |
2004-11-25 |
Abbott Laboratories |
Method of treating transplant rejection
|
|
KR100976076B1
(ko)
|
2003-05-22 |
2010-08-17 |
아보트 러보러터리즈 |
인다졸, 벤즈이속사졸 및 벤즈이소티아졸 키나제 억제제
|
|
SE0301906D0
(sv)
|
2003-06-26 |
2003-06-26 |
Astrazeneca Ab |
New compounds
|
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
EP2256106B1
(en)
|
2003-07-22 |
2015-05-06 |
Astex Therapeutics Limited |
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
US7442698B2
(en)
|
2003-07-24 |
2008-10-28 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
AU2004260689B8
(en)
|
2003-07-29 |
2008-05-15 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
ATE542801T1
(de)
|
2003-08-15 |
2012-02-15 |
Novartis Ag |
Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
|
|
US20050130974A1
(en)
|
2003-10-17 |
2005-06-16 |
Rigel Pharmaceuticals, Inc. |
Benzothiazole compositions and their use as ubiquitin ligase inhibitors
|
|
WO2005037797A1
(en)
|
2003-10-21 |
2005-04-28 |
Pharmacia Corporation |
Substituted pyrazole urea compounds for the treatment of inflammation
|
|
ATE465731T1
(de)
|
2003-10-23 |
2010-05-15 |
Ab Science |
2-aminoaryloxazol-verbindungen als tyrosinkinase- hemmer
|
|
DE10357510A1
(de)
|
2003-12-09 |
2005-07-07 |
Bayer Healthcare Ag |
Heteroarylsubstituierte Benzole
|
|
BRPI0418031A
(pt)
|
2003-12-22 |
2007-04-17 |
Gilead Sciences Inc |
inibidores de quinase fosfonato-substituìdos
|
|
WO2005063709A1
(ja)
|
2003-12-25 |
2005-07-14 |
Nippon Shinyaku Co., Ltd. |
アミド誘導体及び医薬
|
|
PT1735322E
(pt)
|
2004-04-02 |
2012-01-12 |
Novartis Ag |
Derivados de sulfonamido-tiazolopiridina como activadores de glucoquinase úteis para o tratamento de diabetes de tipo 2
|
|
DE102004017438A1
(de)
|
2004-04-08 |
2005-11-03 |
Bayer Healthcare Ag |
Hetaryloxy-substituierte Phenylaminopyrimidine
|
|
US20050228031A1
(en)
|
2004-04-13 |
2005-10-13 |
Bilodeau Mark T |
Tyrosine kinase inhibitors
|
|
DE102004020570A1
(de)
|
2004-04-27 |
2005-11-24 |
Bayer Healthcare Ag |
Substituierte Phenylaminopyrimidine
|
|
GB0411791D0
(en)
|
2004-05-26 |
2004-06-30 |
Cyclacel Ltd |
Compounds
|
|
FR2871158A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
|
MXPA06014247A
(es)
|
2004-06-10 |
2007-03-12 |
Irm Llc |
Compuestos y composiciones como inhibidores de la proteina quinasa.
|
|
DE102004028862A1
(de)
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
US20090118261A1
(en)
|
2004-08-31 |
2009-05-07 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
|
US20060100226A1
(en)
|
2004-09-10 |
2006-05-11 |
Sikorski James A |
2-Thiopyrimidinones as therapeutic agents
|
|
EP2316458A1
(en)
|
2004-09-20 |
2011-05-04 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
|
CA2583096A1
(en)
|
2004-10-15 |
2006-04-20 |
Astrazeneca Ab |
Quinoxalines as b raf inhibitors
|
|
CA2584368A1
(en)
|
2004-10-19 |
2006-04-27 |
Arqule, Inc. |
Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
|
|
US7632854B2
(en)
|
2004-11-17 |
2009-12-15 |
Pfizer Italia S.R.L. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
US8211929B2
(en)
|
2004-12-30 |
2012-07-03 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
|
CA2593428C
(en)
|
2005-01-10 |
2012-04-17 |
Pfizer Inc. |
Pyrrolopyrazoles, potent kinase inhibitors
|
|
AR052559A1
(es)
|
2005-01-21 |
2007-03-21 |
Astex Therapeutics Ltd |
Derivados de pirazol para inhibir cdk's y gsk's
|
|
KR100919905B1
(ko)
|
2005-01-26 |
2009-10-06 |
아이알엠 엘엘씨 |
단백질 키나제 억제제로서의 화합물 및 조성물
|
|
TW200639163A
(en)
|
2005-02-04 |
2006-11-16 |
Genentech Inc |
RAF inhibitor compounds and methods
|
|
EP1847531A4
(en)
|
2005-02-09 |
2009-04-22 |
Takeda Pharmaceutical |
PYRAZOLE DERIVATIVE
|
|
DE102005008310A1
(de)
|
2005-02-17 |
2006-08-24 |
Schering Ag |
Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle
|
|
BRPI0607062A2
(pt)
|
2005-02-28 |
2009-08-04 |
Japan Tobacco Inc |
composto de aminopiridina com atividade inibidora de syk, composição farmacêutica e agente terapêutico compreendendo os mesmos
|
|
FR2884516B1
(fr)
|
2005-04-15 |
2007-06-22 |
Cerep Sa |
Antagonistes npy, preparation et utilisations
|
|
WO2006124731A2
(en)
|
2005-05-12 |
2006-11-23 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
AU2006247322A1
(en)
|
2005-05-16 |
2006-11-23 |
Irm Llc |
Pyrrolopyridine derivatives as protein kinase inhibitors
|
|
MY153898A
(en)
|
2005-06-22 |
2015-04-15 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
EP1926734A1
(en)
|
2005-08-22 |
2008-06-04 |
Amgen Inc. |
Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
|
|
WO2007035428A1
(en)
|
2005-09-15 |
2007-03-29 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
JP4990783B2
(ja)
|
2005-09-30 |
2012-08-01 |
Ｍｓｄ株式会社 |
２−ヘテロアリール置換インドール誘導体
|
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
|
GB0520955D0
(en)
|
2005-10-14 |
2005-11-23 |
Cyclacel Ltd |
Compound
|
|
US8247556B2
(en)
|
2005-10-21 |
2012-08-21 |
Amgen Inc. |
Method for preparing 6-substituted-7-aza-indoles
|
|
US20070149508A1
(en)
|
2005-11-02 |
2007-06-28 |
Targegen, Inc. |
Six membered heteroaromatic inhibitors targeting resistant kinase mutations
|
|
MY151455A
(en)
|
2005-12-21 |
2014-05-30 |
Pfizer Prod Inc |
Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
|
|
WO2007076474A1
(en)
|
2005-12-23 |
2007-07-05 |
Kalypsys, Inc. |
Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases
|
|
DK2495016T3
(da)
|
2005-12-23 |
2019-12-16 |
Ariad Pharma Inc |
Bicykliske heteroarylforbindelser
|
|
WO2007076161A2
(en)
|
2005-12-27 |
2007-07-05 |
Myriad Genetics, Inc |
Compounds with therapeutic activity
|
|
WO2007086584A1
(ja)
|
2006-01-30 |
2007-08-02 |
Meiji Seika Kaisha, Ltd. |
新規ＦａｂＫおよびＦａｂＩ／Ｋ阻害剤
|
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
|
EP2027127A1
(en)
|
2006-05-22 |
2009-02-25 |
Shering Corporation |
Pyrazolo [1, 5-a]pyrimidines as cdk inhibitors
|
|
US20100063049A1
(en)
|
2006-05-26 |
2010-03-11 |
Clifford Jones |
2-carbocycloamino-4-imidazolylpyrimidines as agents for the inhbition of cell proliferation
|
|
EP2046327A1
(en)
|
2006-07-21 |
2009-04-15 |
Astex Therapeutics Limited |
Medical use of cyclin dependent kinases inhibitors
|
|
US8268809B2
(en)
|
2006-09-05 |
2012-09-18 |
Emory University |
Kinase inhibitors for preventing or treating pathogen infection and method of use thereof
|
|
EP2529621B1
(en)
|
2006-09-22 |
2016-10-05 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
JP5415271B2
(ja)
|
2006-10-11 |
2014-02-12 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤としての置換ピロロ−ピラゾール誘導体
|
|
WO2008049856A2
(en)
|
2006-10-25 |
2008-05-02 |
Ingenium Pharmaceuticals Gmbh |
Methods of treating pain using cdk inhibitors
|
|
WO2008054827A2
(en)
|
2006-11-03 |
2008-05-08 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
|
BRPI0720003A2
(pt)
|
2006-12-08 |
2018-09-18 |
Hoffmann La Roche |
pirimidinas substituídas e seu uso como moduladores de jnk
|
|
WO2008079873A2
(en)
|
2006-12-20 |
2008-07-03 |
Bristol-Myers Squibb Company |
Thiazolyl compounds useful as kinase inhibitors
|
|
WO2008074749A1
(en)
|
2006-12-20 |
2008-06-26 |
Nerviano Medical Sciences S.R.L. |
Indazole derivatives as kinase inhibitors for the treatment of cancer
|
|
RU2009122670A
(ru)
|
2006-12-21 |
2011-01-27 |
Плекссикон, Инк. (Us) |
Соединения и способы для модуляции киназ и показания к их применению
|
|
EA017937B1
(ru)
|
2007-02-07 |
2013-04-30 |
Пфайзер Инк. |
ПРОИЗВОДНЫЕ 3-АМИНОПИРРОЛО[3,4-c]ПИРАЗОЛ-5(1H,4H,6H)-КАРБАЛЬДЕГИДА В КАЧЕСТВЕ ИНГИБИТОРОВ РКС
|
|
BRPI0808772A2
(pt)
|
2007-03-14 |
2014-08-12 |
Exelixis Inc |
Inibidores da via de hedgehog
|
|
WO2008124393A1
(en)
|
2007-04-04 |
2008-10-16 |
Irm Llc |
Benzothiazole derivatives and their use as protein kinase inhibitors
|
|
CN101675052A
(zh)
|
2007-04-12 |
2010-03-17 |
辉瑞大药厂 |
作为蛋白酶c抑制剂的3-酰氨基-吡咯并[3,4-c]吡唑-5(1h,4h,6h)甲醛衍生物
|
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
US8242271B2
(en)
|
2007-06-04 |
2012-08-14 |
Avila Therapeutics, Inc. |
Heterocyclic compounds and uses thereof
|
|
JP2010529140A
(ja)
|
2007-06-05 |
2010-08-26 |
エモリー・ユニバーシテイ |
サイクリン依存性キナーゼの選択的阻害剤
|
|
US8222285B2
(en)
|
2007-06-11 |
2012-07-17 |
Bristol-Myers Squibb Company |
1,3-dihydroxy substituted phenylamide glucokinase activators
|
|
US7928140B2
(en)
|
2007-08-02 |
2011-04-19 |
Amgen Inc. |
Benzothiazole PI3 kinase modulators for cancer treatment
|
|
US20090054392A1
(en)
|
2007-08-20 |
2009-02-26 |
Wyeth |
Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
|
WO2009032703A1
(en)
|
2007-08-28 |
2009-03-12 |
Irm Llc |
2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors
|
|
WO2009028655A1
(ja)
|
2007-08-30 |
2009-03-05 |
Takeda Pharmaceutical Company Limited |
複素環化合物およびその用途
|
|
TW200922564A
(en)
|
2007-09-10 |
2009-06-01 |
Curis Inc |
CDK inhibitors containing a zinc binding moiety
|
|
KR100923540B1
(ko)
|
2007-11-23 |
2009-10-27 |
한국과학기술연구원 |
5-아실하이드라진카르보닐-3,4-디치환 피라졸 유도체 및이의 제조방법
|
|
WO2009115572A2
(en)
|
2008-03-21 |
2009-09-24 |
Novartis Ag |
Novel heterocyclic compounds and uses therof
|
|
US20100056524A1
(en)
|
2008-04-02 |
2010-03-04 |
Mciver Edward Giles |
Compound
|
|
GB0806419D0
(en)
|
2008-04-09 |
2008-05-14 |
Ineos Fluor Holdings Ltd |
Process
|
|
US20100197688A1
(en)
|
2008-05-29 |
2010-08-05 |
Nantermet Philippe G |
Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
|
|
TWI490214B
(zh)
|
2008-05-30 |
2015-07-01 |
艾德克 上野股份有限公司 |
苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途
|
|
US8530483B2
(en)
|
2008-05-30 |
2013-09-10 |
Merck Sharp & Dohme Corp. |
Substituted azabenzoxazoles
|
|
WO2009152027A1
(en)
|
2008-06-12 |
2009-12-17 |
Merck & Co., Inc. |
5,7-dihydro-6h-pyrrolo[2,3-d]pyrimidin-6-one derivatives for mark inhibition
|
|
EP2303890A4
(en)
|
2008-06-19 |
2012-04-11 |
Progenics Pharm Inc |
INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
|
|
EP2311842A3
(en)
|
2008-06-24 |
2011-07-13 |
Takeda Pharmaceutical Company Limited |
PI3K/M TOR inhibitors
|
|
GB0812031D0
(en)
|
2008-07-01 |
2008-08-06 |
7Tm Pharma As |
Thiazole derivatives
|
|
TWI450898B
(zh)
|
2008-07-04 |
2014-09-01 |
Sigma Tau Res Switzerland Sa |
具有抗腫瘤活性之芳基異唑化合物
|
|
EP2303881A2
(en)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases
|
|
CA2732520A1
(en)
|
2008-08-05 |
2010-02-11 |
Merck Sharp & Dohme Corp. |
Therapeutic compounds
|
|
WO2010044885A2
(en)
|
2008-10-17 |
2010-04-22 |
Whitehead Institute For Biomedical Research |
Soluble mtor complexes and modulators thereof
|
|
CN101723936B
(zh)
|
2008-10-27 |
2014-01-15 |
上海睿星基因技术有限公司 |
激酶抑制剂及其在药学中的用途
|
|
CA2744713A1
(en)
|
2008-12-05 |
2010-06-10 |
Arqule, Inc. |
Raf inhibitors and their uses
|
|
WO2010075542A1
(en)
|
2008-12-23 |
2010-07-01 |
Curis, Inc. |
Cdk inhibitors
|
|
EP2397479A4
(en)
|
2009-02-12 |
2012-08-01 |
Astellas Pharma Inc |
HETERO RING DERIVATIVE
|
|
WO2010125799A1
(ja)
|
2009-04-27 |
2010-11-04 |
塩野義製薬株式会社 |
Pi3k阻害活性を有するウレア誘導体
|
|
KR101705158B1
(ko)
|
2009-05-05 |
2017-02-09 |
다나-파버 캔서 인스티튜트 인크. |
Ｅｇｆｒ 억제제 및 질환 치료방법
|
|
US20110039873A1
(en)
|
2009-06-08 |
2011-02-17 |
Gaeta Federico C A |
SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY
|
|
WO2010144423A1
(en)
|
2009-06-09 |
2010-12-16 |
Abraxis Bioscience, Llc |
Styryl-triazine derivatives and their therapeutical applications
|
|
US8765747B2
(en)
|
2009-06-12 |
2014-07-01 |
Dana-Farber Cancer Institute, Inc. |
Fused 2-aminothiazole compounds
|
|
FR2948367A1
(fr)
|
2009-07-24 |
2011-01-28 |
Centre Nat Rech Scient |
Derives d'acyl-guanidines modulateurs de la voie de signalisation des proteines hedgehog
|
|
JP2013508285A
(ja)
|
2009-10-14 |
2013-03-07 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｃ型肝炎の処置のための組成物
|
|
WO2011079231A1
(en)
|
2009-12-23 |
2011-06-30 |
Gatekeeper Pharmaceutical, Inc. |
Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
|
|
EP2937345B1
(en)
|
2009-12-29 |
2018-03-21 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
BR112012023021A2
(pt)
|
2010-03-16 |
2016-05-31 |
Dana Farber Cancer Inst Inc |
compostos de indazol e seus usos
|
|
ES2606958T3
(es)
|
2010-05-14 |
2017-03-28 |
Dana-Farber Cancer Institute, Inc. |
Compuestos de tienotriazolodiazepina para tratar una neoplasia
|
|
UY33539A
(es)
|
2010-08-02 |
2012-02-29 |
Astrazeneca Ab |
Compuestos químicos alk
|
|
CN102408408A
(zh)
|
2010-09-20 |
2012-04-11 |
北大方正集团有限公司 |
具有抗肿瘤作用的芳基脲衍生物
|
|
CN102406646B
(zh)
|
2010-09-20 |
2015-09-09 |
北大方正集团有限公司 |
芳基脲衍生物用于制备治疗移植排斥药物的用途
|
|
CN102406644A
(zh)
|
2010-09-20 |
2012-04-11 |
北大方正集团有限公司 |
芳基脲衍生物用于制备治疗移植排斥药物的新用途
|
|
KR20140009259A
(ko)
|
2010-11-19 |
2014-01-22 |
에프. 호프만-라 로슈 아게 |
피라졸로피리딘 및 tyk2 억제제로서 이의 용도
|
|
US8546443B2
(en)
|
2010-12-21 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Benzylic oxindole pyrimidines
|
|
WO2012090219A2
(en)
|
2010-12-31 |
2012-07-05 |
Jubilant Biosys Ltd. |
Thiazole compounds useful as acetyl-coa carboxylase (acc) inhibitors
|
|
WO2013014162A1
(en)
|
2011-07-28 |
2013-01-31 |
Cellzome Limited |
Heterocyclyl pyrimidine analogues as jak inhibitors
|
|
WO2013040436A2
(en)
|
2011-09-16 |
2013-03-21 |
The Regents Of The University Of Michgian |
Esx-mediated transcription modulators and related methods
|
|
MD20140023A2
(ro)
|
2011-09-22 |
2014-06-30 |
Pfizer Inc. |
Derivaţi de pirolpirimidină şi purină
|
|
ES2616242T3
(es)
|
2011-09-28 |
2017-06-12 |
Euro-Celtique S.A. |
Derivados de mostaza de nitrógeno
|
|
JP6106685B2
(ja)
|
2011-11-17 |
2017-04-05 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
Ｃ−ｊｕｎ−ｎ−末端キナーゼ（ｊｎｋ）の阻害剤
|
|
CA2861010A1
(en)
|
2012-01-13 |
2013-07-18 |
Xiao Xu |
Heterocyclic compounds and uses as anticancer agents
|
|
GB201204384D0
(en)
|
2012-03-13 |
2012-04-25 |
Univ Dundee |
Anti-flammatory agents
|
|
WO2013154778A1
(en)
|
2012-04-11 |
2013-10-17 |
Dana-Farber Cancer Institute, Inc. |
Host targeted inhibitors of dengue virus and other viruses
|
|
ES2776365T3
(es)
|
2012-07-09 |
2020-07-30 |
Novartis Ag |
Biomarcadores asociados con inhibidores de CDK
|
|
WO2014015523A1
(en)
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
US10000483B2
(en)
|
2012-10-19 |
2018-06-19 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
|
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
|
CN103319483B
(zh)
|
2012-10-19 |
2016-08-03 |
药源药物化学（上海）有限公司 |
一种利拉列汀重要中间体的制备方法
|
|
ME03000B
(me)
|
2012-12-21 |
2018-10-20 |
Plexxikon Inc |
Jedinjenja i metode modulacije kinaze i povezane indikacije
|
|
TWI621618B
(zh)
|
2013-03-13 |
2018-04-21 |
比利時商健生藥品公司 |
經取代２－氮雜雙環類及其作為食慾素受體調控劑之用途
|
|
TW201444821A
(zh)
|
2013-03-13 |
2014-12-01 |
Janssen Pharmaceutica Nv |
經取代之哌啶化合物及其作為食慾素受體調節劑之用途
|
|
US10138256B2
(en)
|
2013-03-15 |
2018-11-27 |
Celgene Car Llc |
MK2 inhibitors and uses thereof
|
|
AU2014234472A1
(en)
|
2013-03-20 |
2015-10-29 |
Bayer Pharma Aktiengesellschaft |
3-acetylamino-1-(phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino)benzene derivatives for the treatment of hyperproliferative disorders
|
|
US9938279B2
(en)
|
2013-04-09 |
2018-04-10 |
Energenesis Biomedical Co., Ltd |
Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)
|
|
CN103242341B
(zh)
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
|
|
CN104177363B
(zh)
|
2013-05-24 |
2018-06-05 |
江苏先声药业有限公司 |
双环杂环胺类Hedgehog信号通路抑制剂
|
|
BR112016000195A8
(pt)
|
2013-07-11 |
2019-12-31 |
Acea Biosciences Inc |
compostos heterocíclicos, composição farmacêutica, combinação, seu uso, e método para inibir uma atividade da tirosina quinase btk ou jak, egfr, alk, pdgfr, blk, bmx/etk, flt3(d835y), itk, tec, txk, e suas respectivas vias
|
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
|
US10273224B2
(en)
|
2013-08-22 |
2019-04-30 |
Jubilant Biosys Limited |
Substituted pyrimidine compounds, compositions and medicinal applications thereof
|
|
WO2015058163A2
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
WO2015058126A1
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of prolferative diseases
|
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
USRE50030E1
(en)
|
2013-12-13 |
2024-07-02 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
MX2016009974A
(es)
|
2014-01-31 |
2016-10-31 |
Dana Farber Cancer Inst Inc |
Derivados de diaminopirimidina bencensulfona y sus usos.
|
|
EP3099693A4
(en)
|
2014-01-31 |
2017-08-16 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
KR20160111520A
(ko)
|
2014-01-31 |
2016-09-26 |
다나-파버 캔서 인스티튜트 인크. |
디히드로프테리디논 유도체 및 그의 용도
|
|
WO2015117083A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
|
CN104860941B
(zh)
|
2014-02-25 |
2017-03-22 |
上海海雁医药科技有限公司 |
2,4‑二取代苯‑1,5‑二胺衍生物及其应用以及由其制备的药物组合物和药用组合物
|
|
MX358346B
(es)
|
2014-04-04 |
2018-08-15 |
Syros Pharmaceuticals Inc |
Inhibidores de la quinasa dependiente de ciclina 7 (cdk7).
|
|
EP3805218A1
(en)
|
2014-04-05 |
2021-04-14 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
|
CN104829610B
(zh)
|
2014-06-20 |
2017-03-15 |
中国科学院合肥物质科学研究院 |
一种新型布鲁顿酪氨酸激酶抑制剂
|
|
CA2954186A1
(en)
|
2014-07-21 |
2016-01-28 |
Dana-Farber Cancer Institute, Inc. |
Imidazolyl kinase inhibitors and uses thereof
|
|
WO2016014551A1
(en)
|
2014-07-21 |
2016-01-28 |
Dana-Farber Cancer Institute, Inc. |
Macrocyclic kinase inhibitors and uses thereof
|
|
WO2016014904A1
(en)
|
2014-07-24 |
2016-01-28 |
Beta Pharma, Inc. |
2-h-indazole derivatives as cyclin-dependent kinase (cdk) inhibitors and therapeutic uses thereof
|
|
WO2016058544A1
(en)
|
2014-10-16 |
2016-04-21 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
US10131679B2
(en)
|
2014-10-31 |
2018-11-20 |
Ube Industries, Ltd. |
Substituted dihydropyrrolopyrazole compound
|
|
US10870651B2
(en)
|
2014-12-23 |
2020-12-22 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
US9708324B2
(en)
|
2015-02-05 |
2017-07-18 |
Merck Patent Gmbh |
Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
|
|
EP3268000B1
(en)
|
2015-03-09 |
2021-08-04 |
Aurigene Discovery Technologies Limited |
Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
|
|
CN107427521B
(zh)
|
2015-03-27 |
2021-08-03 |
达纳-法伯癌症研究所股份有限公司 |
细胞周期蛋白依赖性激酶的抑制剂
|
|
DK3302448T3
(da)
|
2015-06-04 |
2024-02-05 |
Aurigene Oncology Ltd |
Erstattede heterocyclylafledninger som cdk-inhibitore
|
|
CA2986441A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
AU2016283105C1
(en)
|
2015-06-26 |
2023-02-02 |
Dana-Farber Cancer Institute, Inc. |
4,6-pyrimidinylene derivatives and uses thereof
|
|
HK1254469A1
(zh)
|
2015-06-26 |
2019-07-19 |
Dana Farber Cancer Institute, Inc. |
稠合双环嘧啶衍生物及其用途
|
|
US20180243304A1
(en)
|
2015-08-28 |
2018-08-30 |
Novartis Ag |
Pharmaceutical combinations comprising (a) the cyclin dependent kinase 4/6 (cdk4/6) inhibitor lee011 (=ribociclib), and (b) the epidermal growth factor receptor (egfr) inhibitor erlotinib, for the treatment or prevention of cancer
|
|
WO2017044858A2
(en)
|
2015-09-09 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
WO2017160717A2
(en)
|
2016-03-15 |
2017-09-21 |
Memorial Sloan Kettering Cancer Center |
Method of treating diseases using kinase modulators
|
|
JP7258748B2
(ja)
|
2016-11-22 |
2023-04-17 |
ダナ－ファーバー キャンサー インスティテュート， インコーポレイテッド |
サイクリン依存性キナーゼ１２（ｃｄｋ１２）の阻害剤およびその使用
|
|
AU2017363390A1
(en)
|
2016-11-28 |
2019-06-13 |
Dana-Farber Cancer Institute, Inc. |
Reagents and methods for analysis of proteins and metabolites targeted by covalent probes
|
|
CN107235906B
(zh)
|
2017-06-28 |
2020-05-01 |
郑州大学第一附属医院 |
一组吡唑酰胺类衍生物及其应用
|
|
CN107686477B
(zh)
|
2017-09-30 |
2020-01-31 |
武汉九州钰民医药科技有限公司 |
作为cdk4/6抑制剂的新型化合物及其应用
|
|
EP3810132A4
(en)
|
2018-06-25 |
2022-06-22 |
Dana-Farber Cancer Institute, Inc. |
TAIRE FAMILY KINASE INHIBITORS AND RELATED USES
|
|
JP7530297B2
(ja)
|
2018-11-14 |
2024-08-07 |
Ｕｂｅ株式会社 |
ジヒドロピロロピラゾール誘導体
|
|
CN113164477A
(zh)
|
2018-12-14 |
2021-07-23 |
达纳-法伯癌症研究所股份有限公司 |
C-jun-n-末端激酶的吡唑并吡啶抑制剂及其用途
|
|
EP3902542A4
(en)
|
2018-12-28 |
2022-09-07 |
Dana-Farber Cancer Institute, Inc. |
CYCLIN DEPENDENT KINASE 7 INHIBITORS AND USES THEREOF
|
|
US12365696B2
(en)
|
2019-05-10 |
2025-07-22 |
Dana-Farber Cancer Institute, Inc. |
Small-molecule focal adhesion kinase (FAK) inhibitors
|
|
JP7680999B2
(ja)
|
2019-07-23 |
2025-05-21 |
ダナ－ファーバー キャンサー インスティテュート， インコーポレイテッド |
サイクリン依存性キナーゼ７のインヒビターおよびそれらの使用
|
|
CN114174281B
(zh)
|
2019-08-05 |
2025-02-07 |
达纳-法伯癌症研究公司 |
细胞周期蛋白依赖性激酶7(cdk7)的降解剂及其用途
|
|
CA3166135A1
(en)
|
2019-12-24 |
2021-07-01 |
Dana-Farber Cancer Institute, Inc. |
The combination of cyclin dependent kinase 7 inhibitor and immunotherapy for treatment of cancer
|